Trial of Adjuvant Chemotherapy for Gastric Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

855

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2009

Conditions
Stomach Cancer
Interventions
DRUG

Mitomycin, doxifluridine and cisplatin

Mitomycin-C 20mg/m2 intravenously (day 1), Doxifluridine 460-600mg/m2/day per oral (day 28- day 336), Cisplatin 60mg/m2 intravenously (day 28, day 56, day 84, day 112, day 140, and day 168)

DRUG

Mitomycin and doxifluridine

Mitomycin-C 20mg/m2 intravenously (day 1), Doxifluridine 460-600mg/m2/day per oral (day 28-day 84)

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Ulsan University Hospital

OTHER

collaborator

Hallym University Medical Center

OTHER

lead

Asan Medical Center

OTHER

NCT00296335 - Trial of Adjuvant Chemotherapy for Gastric Cancer | Biotech Hunter | Biotech Hunter